SemBioSys Genetics

SemBioSys' newly issued 20th U.S. patent addresses antibody production and oilbodies

Published in Hospital and Nursing Home Week, October 5th, 2006

SemBioSys Genetics Inc. (SBS), a biotechnology company developing protein-based pharmaceuticals and nonpharmaceutical products, announced it has been granted U.S. patent 7,098,383 entitled "Methods for the production of multimeric immunoglobulins, and related compositions."

The claims of the patent are directed to the production of antibodies in association with oilbodies.

In addition to the current patent, SemBioSys was also issued another U.S. patent 7,091,401 entitled "Expression of Epidermal Growth Factor (EGF) in plant seeds" on August 15, 2006, which covers chimeric nucleic acid sequences and methods of expression of EGF in plants and plant...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week

Source: Hospital and Nursing Home Week (2006-10-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry